Effects of

CYP3A5 genotype allogeneic hematopoietic stem cell transplantation graft-versus-host disease preemptive pharmacogenetics tacrolimus therapeutic drug monitoring

Journal

Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453

Informations de publication

Date de publication:
25 Apr 2024
Historique:
received: 02 03 2024
revised: 18 04 2024
accepted: 22 04 2024
medline: 25 5 2024
pubmed: 25 5 2024
entrez: 25 5 2024
Statut: epublish

Résumé

Tacrolimus (Tac) is pivotal in preventing acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (alloHSCT). It has been reported that genetic factors, including

Identifiants

DOI: 10.3390/ph17050553 PMID: 38794124
pubmed: 38794124
pii: ph17050553
doi: 10.3390/ph17050553
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Daniel N Marco (DN)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0003-3412-7563

Mònica Molina (M)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Ana-María Guio (AM)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Judit Julian (J)

Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, IDIBAPS, CIBERehd, Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0009-0008-7137-9210

Virginia Fortuna (V)

Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, IDIBAPS, CIBERehd, Hospital Clínic, 08036 Barcelona, Spain.

Virginia-Lucila Fabregat-Zaragoza (VL)

Department of Immunology, Hospital Clínic, 08036 Barcelona, Spain.

María-Queralt Salas (MQ)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0003-4567-3682

Inés Monge-Escartín (I)

Department of Pharmacy, Pharmacy Service, Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0001-9959-9102

Gisela Riu-Viladoms (G)

Department of Pharmacy, Pharmacy Service, Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0002-8259-0811

Esther Carcelero (E)

Department of Pharmacy, Pharmacy Service, Hospital Clínic, 08036 Barcelona, Spain.

Joan Ramón Roma (JR)

Department of Pharmacy, Pharmacy Service, Hospital Clínic, 08036 Barcelona, Spain.

Noemí Llobet (N)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Jordi Arcarons (J)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

María Suárez-Lledó (M)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Laura Rosiñol (L)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0002-2534-9239

Francesc Fernández-Avilés (F)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0002-3733-590X

Montserrat Rovira (M)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Mercè Brunet (M)

Pharmacology and Toxicology Laboratory, Biochemistry and Molecular Genetics Department, Biomedical Diagnostic Center, IDIBAPS, CIBERehd, Hospital Clínic, 08036 Barcelona, Spain.

Carmen Martínez (C)

Hematopoietic Stem Cell Transplantation Unit, Hematology Department, Institute of Cancer and Hematological Diseases, Instituto de Investigación Biomédica August Pi i Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.
ORCID: 0000-0002-8401-7306

Classifications MeSH